Novo Nordisk A/S News - August 2026

Eli Lilly wins FDA heart approval for Mounjaro, intensifying Novo Nordisk rivalry

The FDA approved Eli Lilly’s Mounjaro to reduce risks of heart attack, stroke, and cardiovascular death in high-risk adults with type 2 diabetes. This decision...

Novo Nordisk partners with AWS to accelerate drug discovery via London hub

Novo Nordisk and Amazon Web Services (AWS) have established a strategic partnership to accelerate drug discovery using artificial intelligence and cloud...